DRC Ebola Outbreak: Potential Treatment Trial Begins
Summary
A clinical trial has commenced in the Democratic Republic of Congo for a potential treatment against the Bundibugyo strain of Ebola amid over 1,400 confirmed infections and 438 deaths.
Key Points
- A clinical trial for a potential treatment against the Bundibugyo strain of Ebola has begun in the Democratic Republic of Congo.
- More than 1,400 Ebola infections and 438 deaths have been confirmed in Congo so far.
- The trial is coordinated by Congo's National Institute of Biomedical Research, Belgium's Institute of Tropical Medicine, and UK's Oxford University with WHO financial support.
- WHO declared the outbreak a public health emergency affecting Congo, Uganda, and a case in France.
